<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-103061</identifier>
<setSpec>0210-5691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">A prospective, observational severe sepsis/septic shock registry in a tertiary hospital in the province of Guipuzcoa (Spain)</dc:title>
<dc:description xml:lang="en">Objective: To determine the epidemiological and clinical characteristics of the patients with severe sepsis/septic shock admitted to the ICU of Donostia Hospital (Guipuzcoa, Spain), analyzing the prognostic factors and comparing them with the existing data at national level. Design: A prospective observational study was carried out during a consecutive 3-year period (1 Feb. 2008-31 Dec. 2010). Setting: The ICU of Donostia Hospital, the only third level hospital in the province of Guipúzcoa, with a recruitment population of 700,000 inhabitants. Results: In the course of the study period, 6,263 patients were admitted to our Department: 2,880 were non-coronary patients, and 511 suffered a severe sepsis or septic shock episode upon admission or during their stay in the ICU. Males predominated (66.5%), the mean age was 63 years, and the mean Acute Physiology And Chronic Health Evaluation II (APACHE II) score was 21. Most cases were medical (68%) and were admitted from hospital wards (53.5%). The most frequent origin was pneumonia (24%). The great majority of the cases (73%) corresponded to septic shock. Hemodynamic alterations were the most frequent disorders, followed by renal and respiratory impairment. Noradrenalin was used as vasoactive drug in all shock patients; over one-half required mechanical ventilation (MV), and one third required continuous venous-venous hemodiafiltration (CVVHDF). Interventions frequently used in the management of these patients comprised blood cultures or corticosteroid use, while other measures such as activated protein C were little used. The mortality rate in the ICU was 20.8%, with a mean stay in the Unit of 14 days. The parameters associated to mortality in the multivariate analysis included the presence of hypoglycemia, respiratory dysfunction, the need for MV, lactic acid elevation and  (..) (AU)</dc:description>
<dc:creator>Sebastián, R</dc:creator>
<dc:creator>Pascal, M</dc:creator>
<dc:creator>Salas, E</dc:creator>
<dc:creator>Cabarcos, E</dc:creator>
<dc:creator>Azkárate, I</dc:creator>
<dc:creator>Choperena, G</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Conocer las características epidemiológicas y clínicas de los pacientes con sepsis grave/shock séptico ingresados en la unidad de cuidados intensivos del Hospital Donostia, analizar factores pronósticos y compararlos con los datos existentes a nivel nacional. Diseño: Estudio observacional prospectivo durante un periodo consecutivo de 3 años (1 de febrero de 2008-31 de diciembre de 2010). Ámbito: Unidad de cuidados intensivos (UCI) del Hospital Donostia, único hospital de tercer nivel de la provincia de Guipúzcoa, que atiende a una población de 700.000 habitantes. Resultados: A lo largo de este periodo, 6.263 pacientes ingresaron en nuestro servicio; 2.880 fueron pacientes no coronarios y 511 presentaron al ingreso o en su evolución en UCI, un episodio de sepsis grave o shock séptico. Hubo un predominio de varones (66,5%), con una edad media de 63 años y Acute Physiology And Chronic Health Evaluation II (APACHE II) medio de 21. La mayoría fueron de tipo médico (68%), procedentes de planta de hospitalización(53,5%) y el origen más frecuente fue la neumonía (24%). La gran mayoría (73%) presentó shock séptico. La afectación hemodinámica fue la más frecuente, seguida de la renal y respiratoria. En todos los pacientes con shock se utilizó noradrenalina como vasopresor, más de la mitad requirieron ventilación mecánica (VM) y un tercio, hemodiafiltración venovenosa continua (HDFVVC). En el manejo de estos (..)(AU)</dc:description>
<dc:source>Med. intensiva (Madr., Ed. impr.);36(4): 250-256, mayo 2012. tab</dc:source>
<dc:identifier>ibc-103061</dc:identifier>
<dc:title xml:lang="es">Registro observacional y prospectivo de sepsis grave/shock séptico en un hospital terciario de la provincia de Guipúzcoa</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d3439^s22045</dc:subject>
<dc:subject>^d50271</dc:subject>
<dc:subject>^d7530^s22083</dc:subject>
<dc:subject>^d32031^s22080</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d13150^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>201205</dc:date>
</metadata>
</record>
</ibecs-document>
